These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32699301)

  • 21. Reducing endogenous insulin is linked with protection against hepatic steatosis in mice.
    Akheruzzaman M; Hegde V; Shin AC; Dhurandhar NV
    Nutr Diabetes; 2020 Apr; 10(1):11. PubMed ID: 32286259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue.
    França LM; Dos Santos PC; Barroso WA; Gondim RSD; Coêlho CFF; Flister KFT; Paes AMA
    J Dev Orig Health Dis; 2020 Oct; 11(5):509-520. PubMed ID: 32594969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.
    Onofrio LI; Arocena AR; Paroli AF; Cabalén ME; Andrada MC; Cano RC; Gea S
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003464. PubMed ID: 25668433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of hepatic steatosis by dietary fatty acids.
    Ferramosca A; Zara V
    World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model.
    Leibowitz A; Bier A; Gilboa M; Peleg E; Barshack I; Grossman E
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
    Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA
    Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice.
    He C; Cheng D; Wang H; Wu K; Zhu Y; Lu N
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):360-367. PubMed ID: 29657020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Ramos IP; da Silva IJ; Machado MP; Miranda RA; Pazos-Moura CC; Gonçalves-de-Albuquerque CF; Faria-Neto HCC; Tibiriça E; Daliry A
    PLoS One; 2017; 12(6):e0179654. PubMed ID: 28628674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.
    Hubel E; Fishman S; Holopainen M; Käkelä R; Shaffer O; Houri I; Zvibel I; Shibolet O
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(3):G298-G307. PubMed ID: 34259586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.
    Tanaka K; Masaki Y; Tanaka M; Miyazaki M; Enjoji M; Nakamuta M; Kato M; Nomura M; Inoguchi T; Kotoh K; Takayanagi R
    World J Gastroenterol; 2014 Mar; 20(10):2653-63. PubMed ID: 24627601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.
    Chong MF; Hodson L; Bickerton AS; Roberts R; Neville M; Karpe F; Frayn KN; Fielding BA
    Am J Clin Nutr; 2008 Apr; 87(4):817-23. PubMed ID: 18400702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects.
    Hudgins LC; Baday A; Hellerstein MK; Parker TS; Levine DM; Seidman CE; Neese RA; Tremaroli JD; Hirsch J
    J Nutr Biochem; 2008 Apr; 19(4):237-45. PubMed ID: 17618104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
    Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
    Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
    Luukkonen PK; Qadri S; Ahlholm N; Porthan K; Männistö V; Sammalkorpi H; Penttilä AK; Hakkarainen A; Lehtimäki TE; Gaggini M; Gastaldelli A; Ala-Korpela M; Orho-Melander M; Arola J; Juuti A; Pihlajamäki J; Hodson L; Yki-Järvinen H
    J Hepatol; 2022 Mar; 76(3):526-535. PubMed ID: 34710482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption.
    Sanders FWB; Acharjee A; Walker C; Marney L; Roberts LD; Imamura F; Jenkins B; Case J; Ray S; Virtue S; Vidal-Puig A; Kuh D; Hardy R; Allison M; Forouhi N; Murray AJ; Wareham N; Vacca M; Koulman A; Griffin JL
    Genome Biol; 2018 Jun; 19(1):79. PubMed ID: 29925420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.